The prevalence of cervical HPV and cytological abnormalities in association with reproductive factors of rural Nigerian women

Journal of Women's Health

Volumn 17, Issue 2, 2008, Pages 279-285

  Schnatz, Peter F ^a,b   Markelova, Natalia V ^a   Holmes, Danielle ^a,b   Mandavilli, Srinivas R ^a   O'Sullivan, David M ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AFRICA; AGED; ARTICLE; ATYPICAL GLANDULAR CELL; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CANDIDA; DEMOGRAPHY; FEMALE; HEALTH CARE ACCESS; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; NIGERIA; NONHUMAN; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; RURAL POPULATION; TRICHOMONAS VAGINALIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MASS SCREENING; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; RURAL POPULATION; VAGINAL SMEARS; WOMEN'S HEALTH;

EID: 43049091225     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0295     Document Type: Article

References (33)

1. Henderson JW. Cost-effectiveness of cervical cancer screening strategies. Expert Rev Pharmacoecon Outcomes Res 2004;4:287.
2. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence that human papillomavirus causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus infection is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12.
4. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst 2003;95:46.
5. Concepcion Bratti M, Rodriguez AC, Schiffman M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica/Pan Am J Public Health 2004;15:75.
6. Central Intelligence Agency. The world factbook. Available at www.cia.gov/cia/publications/factbook/index. html Information on Nigeria available at www.cia.gov/ cia/publications/factbook/geos/ni.html Accessed March 27, 2007.
7. Wikipedia, The free encyclopedia. en.wikipedia.org/wiki/Main_Page Geographic areas located at en.wikipedia.org/wiki/Nigeria en.wikipedia.org/wiki/France and en.wikipedia. org/wiki/Texas Accessed March 27, 2007.
8. Population, health and human well-being - Public health: Physicians per 100,000 people. Available at earthtrends.wri.org/text/population-health/ variable-1297.html Accessed November 21, 2006.
9. World Health Organization Statistical Information System (WHOSIS). Core health indicators: Comparison on core health indicator within WHO region: Nigeria (compared with other countries in WHO African region). Indicator: Child mortality per 1000, 2004. [Probability of dying before age 5]. Available at www3.who.int/whosis/country/compare.cfm?country=NGA&indicator= MortChildMale,MortChildFemale&language =english Accessed March 28, 2007.
10. Ajayi IO, Adewole IF. Breast and cervical cancer screening activities among family physicians in Nigeria. Afr J Med Med Sci 2002;32:305.
11. Emembolu JO, Ekwempu CC. Carcinoma of the cervix uteri in Zaria: Etiological factors. Int J Gynaecol Obstet 1988;26:265.
12. Ijaiya MA, Aboyeji PA, Buhari MO. Cancer of the cervix in Ilorin, Nigeria. West Afr J Med 2004;23:319.
13. Chirenje ZM, Rusakaniko S, Akino V, Mlingo M. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998. Cent Afr J Med 2000;46:264.
14. Adewole IF, Benedet JL, Crain BT, Follen M. Evolving a strategic approach to cervical cancer control in Africa. Gynecol Oncol 2005;99:S209.
15. The Christian Medical Fellowship. Available at www.c-m-f.org Accessed March 28, 2007.
16. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan Nigeria: A population-based study. Br J Cancer 2004;90:638.
17. Amrani M, Lalaoui K, El Mzibri M, Lazo P, Belabbas MA. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol 2003;27:286.
18. Petry KU, Scholz U, Hollwitz B, Von Wasieleewski R, Meijer CJLM. Human papillomavirus, coinfection with Schistosoma haematobium, and cervical neoplasia in rural Tanzania. Int J Gynecol Cancer 2003;13:505.
19. Xi LF, Toure P, Critchlow CW, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened West African women over 35 years of age. Int J Cancer 2003;103:803.
20. Mayaud P, Weiss HA, Lacey CJN, Gill DK, Mabey DCW. Genital human papillomavirus genotypes in northwestern Tanzania. J Clin Microbiol 2003;41:4451.
21. De Vuyst H, Steyaert S, Van Renterghem L, et al. Distribution of human papillomaviruse in family planning population in Nairobi, Kenia. Sex Transm Dis 2003;30:137.
22. Gravitt PE, Kamath AM, Gaffikin L, Chirenje ZM, Womack S, Shah KV. Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe. Int J Cancer 2002;100:729.
23. Castellsague X, Menendez C, Loscertales MP, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001;358:1429.
24. Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC Jr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000;89:826.
25. Womack SD, Chirenje ZM, Blumenthal PD, et al. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. Br J Obstet Gynaecol 2000; 107:33.
26. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818.
27. Serwadda D, Wawer MJ, Shah KV, et al. Use of hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis 1999;180:1316.
28. Chaouki N, Bosch FX, Munoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546.
29. Chabaud M, Le Cann P, Mayelo V, et al. Detecton by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J Med Virol 1996;49:259.
30. Czegledy J, Rogo KO, Evander M, Wadell G. Highrisk human papillomavirus types in cytologically normal cervical scrapes from Kenya. Med Microbiol Immunol (Berl) 1992;180:321.
31. Christopherson WM, Lundin FE, Mendez WM, Parker JE. Cevical cancer control: A study of morbidity and mortality trends over a twenty-one year period. Cancer 1976;38:1357.
32. The National Cancer Institute. Surveillance epidemiology and end results (SEER) (seer.cancer.gov/). Cancer Stat Fact Sheets: Cancer of the cervix uteri. Available at seer.cancer.gov/statfacts/html/cervix.html Accessed February 14, 2007.
33. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programs. Lancet 1987;1:1247.